New Investigator Sponsored Data Suggest Trilaciclib May Mitigate Chemotherapy-Induced TP53-Mutant Clonal Hematopoiesis
MORRISTOWN, NJ, UNITED STATES, December 7, 2025 /EINPresswire.com/ -- Pharmacosmos Therapeutics Inc. today announced the presentation of new investigator-sponsored research at the 67th American Society of Hematology (ASH) Annual Meeting and …